Bio Path Holdings Inc (BPTH)

[Snug9]

Unfortuanately GP, while the 10:1 RS is a tool that may allow for a positive outcome it is also a statement of the incredibly poor management which is PN and his team.
Puma Bio (PBYI) received conditional, drug of last resort, approval on their treatment for breast cancer and their stock is trading at about $130 per share today. Juno Therapuetics (JUNO) had a couple of deaths attributed to their phase I trials and they are trading around $56 per share today and, I believe, in phase II today.
This is Peter’s show and his arrogance is responsible for the dismal performance of BPTH stock. I believe the shorters will smell blood in the water and there would be a shorter feeding frenzy if the share price gets high enough to attract their attention through a reverse split.